FusionFormer: A Multi-sensory Fusion in Bird's-Eye-View and Temporal Consistent Transformer for 3D Objection

Multi-sensor modal fusion has demonstrated strong advantages in 3D object detection tasks. However, existing methods that fuse multi-modal features through a simple channel concatenation require transformation features into bird's eye view space and may lose the information on Z-axis thus leads to inferior performance. To this end, we propose FusionFormer, an end-to-end multi-modal fusion framework that leverages transformers to fuse multi-modal features and obtain fused BEV features. And based on the flexible adaptability of FusionFormer to the input modality representation, we propose a depth prediction branch that can be added to the framework to improve detection performance in camera-based detection tasks. In addition, we propose a plug-and-play temporal fusion module based on transformers that can fuse historical frame BEV features for more stable and reliable detection results. We evaluate our method on the nuScenes dataset and achieve 72.6% mAP and 75.1% NDS for 3D object detection tasks, outperforming state-of-the-art methods

Pre-treatment functional connectivity of the cingulate cortex predicts anti-suicidal effects of serial ketamine infusions

Abstract Background Although ketamine can rapidly decrease suicidal ideation (SI), its neurobiological mechanism of action remains unclear. Several areas of the cingulate cortex have been implicated in SI; therefore, we aimed to explore the neural correlates of the anti-suicidal effect of ketamine with cingulate cortex functional connectivity (FC) in depression. Methods Forty patients with unipolar or bipolar depression with SI underwent six infusions of ketamine over 2 weeks. Clinical symptoms and resting-state functional magnetic resonance imaging data were obtained at baseline and on day 13. Remitters were defined as those with complete remission of SI on day 13. Four pairs of cingulate cortex subregions were selected: the subgenual anterior cingulate cortex (sgACC), pregenual anterior cingulate cortex (pgACC), anterior mid-cingulate cortex (aMCC), and posterior mid-cingulate cortex (pMCC), and whole-brain FC for each seed region was calculated. Results Compared with non-remitters, remitters exhibited increased FC of the right pgACC–left middle occipital gyrus (MOG) and right aMCC–bilateral postcentral gyrus at baseline. A high area under the curve (0.91) indicated good accuracy of the combination of the above between-group differential FCs as a predictor of anti-suicidal effect. Moreover, the change of SI after ketamine infusion was positively correlated with altered right pgACC–left MOG FC in remitters (r = 0.66, p = 0.001). Conclusions Our findings suggest that the FC of some cingulate cortex subregions can predict the anti-suicidal effect of ketamine and that the anti-suicidal mechanism of action of ketamine may involve alteration of FC between the right pgACC and left MOG

2023 Low-Power Computer Vision Challenge (LPCVC) Summary

This article describes the 2023 IEEE Low-Power Computer Vision Challenge (LPCVC). Since 2015, LPCVC has been an international competition devoted to tackling the challenge of computer vision (CV) on edge devices. Most CV researchers focus on improving accuracy, at the expense of ever-growing sizes of machine models. LPCVC balances accuracy with resource requirements. Winners must achieve high accuracy with short execution time when their CV solutions run on an embedded device, such as Raspberry PI or Nvidia Jetson Nano. The vision problem for 2023 LPCVC is segmentation of images acquired by Unmanned Aerial Vehicles (UAVs, also called drones) after disasters. The 2023 LPCVC attracted 60 international teams that submitted 676 solutions during the submission window of one month. This article explains the setup of the competition and highlights the winners' methods that improve accuracy and shorten execution time.Comment: LPCVC 2023, website: https://lpcv.ai

Variasi Temperatur Pencampuran Terhadap Parameter Marshall Pada Campuran Lapis Aspal Beton

This study was conducted to determine the effect of temperature variations on the mixing processof the asphalt concrete AC-WC (Asphalt Concrete-Wearing Course) subtle gradations in themiddle limit and lower limit of the Marshall parameters with reference to specifications of BinaMarga, 2010.From the results of experiments conducted that the optimum asphalt content is used to middle limitusing a asphalt content of 5,7% and 6,8% for the lower limit after that mixing was done usingtemperature variation of 120 o C, 130 o C, 140 o C, 150 o C, and 160 o C.To a mixture of Laston AC-WC subtle gradations middle limit grading 5,7% asphalt contentmixing temperature using a temperature of 120 o C, 130 o C, 140 o C, 150 o C, 160 o C and still meet allstandards of marshall parameters. Ideal mixing temperature variations in the middle limit ofmixing temperature 150 o C-160 o C. While the lower limit to the level of 6,8% asphalt contentmixing temperatures between 120 o C-160 o C did not meet the specifications, because the MQ valuebelow the minimum value of 250 kg / mm

Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

Background: Understanding the health consequences associated with exposure to risk factors is necessary to inform public health policy and practice. To systematically quantify the contributions of risk factor exposures to specific health outcomes, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 aims to provide comprehensive estimates of exposure levels, relative health risks, and attributable burden of disease for 88 risk factors in 204 countries and territories and 811 subnational locations, from 1990 to 2021. Methods: The GBD 2021 risk factor analysis used data from 54 561 total distinct sources to produce epidemiological estimates for 88 risk factors and their associated health outcomes for a total of 631 risk–outcome pairs. Pairs were included on the basis of data-driven determination of a risk–outcome association. Age-sex-location-year-specific estimates were generated at global, regional, and national levels. Our approach followed the comparative risk assessment framework predicated on a causal web of hierarchically organised, potentially combinative, modifiable risks. Relative risks (RRs) of a given outcome occurring as a function of risk factor exposure were estimated separately for each risk–outcome pair, and summary exposure values (SEVs), representing risk-weighted exposure prevalence, and theoretical minimum risk exposure levels (TMRELs) were estimated for each risk factor. These estimates were used to calculate the population attributable fraction (PAF; ie, the proportional change in health risk that would occur if exposure to a risk factor were reduced to the TMREL). The product of PAFs and disease burden associated with a given outcome, measured in disability-adjusted life-years (DALYs), yielded measures of attributable burden (ie, the proportion of total disease burden attributable to a particular risk factor or combination of risk factors). Adjustments for mediation were applied to account for relationships involving risk factors that act indirectly on outcomes via intermediate risks. Attributable burden estimates were stratified by Socio-demographic Index (SDI) quintile and presented as counts, age-standardised rates, and rankings. To complement estimates of RR and attributable burden, newly developed burden of proof risk function (BPRF) methods were applied to yield supplementary, conservative interpretations of risk–outcome associations based on the consistency of underlying evidence, accounting for unexplained heterogeneity between input data from different studies. Estimates reported represent the mean value across 500 draws from the estimate's distribution, with 95% uncertainty intervals (UIs) calculated as the 2·5th and 97·5th percentile values across the draws. Findings: Among the specific risk factors analysed for this study, particulate matter air pollution was the leading contributor to the global disease burden in 2021, contributing 8·0% (95% UI 6·7–9·4) of total DALYs, followed by high systolic blood pressure (SBP; 7·8% [6·4–9·2]), smoking (5·7% [4·7–6·8]), low birthweight and short gestation (5·6% [4·8–6·3]), and high fasting plasma glucose (FPG; 5·4% [4·8–6·0]). For younger demographics (ie, those aged 0–4 years and 5–14 years), risks such as low birthweight and short gestation and unsafe water, sanitation, and handwashing (WaSH) were among the leading risk factors, while for older age groups, metabolic risks such as high SBP, high body-mass index (BMI), high FPG, and high LDL cholesterol had a greater impact. From 2000 to 2021, there was an observable shift in global health challenges, marked by a decline in the number of all-age DALYs broadly attributable to behavioural risks (decrease of 20·7% [13·9–27·7]) and environmental and occupational risks (decrease of 22·0% [15·5–28·8]), coupled with a 49·4% (42·3–56·9) increase in DALYs attributable to metabolic risks, all reflecting ageing populations and changing lifestyles on a global scale. Age-standardised global DALY rates attributable to high BMI and high FPG rose considerably (15·7% [9·9–21·7] for high BMI and 7·9% [3·3–12·9] for high FPG) over this period, with exposure to these risks increasing annually at rates of 1·8% (1·6–1·9) for high BMI and 1·3% (1·1–1·5) for high FPG. By contrast, the global risk-attributable burden and exposure to many other risk factors declined, notably for risks such as child growth failure and unsafe water source, with age-standardised attributable DALYs decreasing by 71·5% (64·4–78·8) for child growth failure and 66·3% (60·2–72·0) for unsafe water source. We separated risk factors into three groups according to trajectory over time: those with a decreasing attributable burden, due largely to declining risk exposure (eg, diet high in trans-fat and household air pollution) but also to proportionally smaller child and youth populations (eg, child and maternal malnutrition); those for which the burden increased moderately in spite of declining risk exposure, due largely to population ageing (eg, smoking); and those for which the burden increased considerably due to both increasing risk exposure and population ageing (eg, ambient particulate matter air pollution, high BMI, high FPG, and high SBP). Interpretation: Substantial progress has been made in reducing the global disease burden attributable to a range of risk factors, particularly those related to maternal and child health, WaSH, and household air pollution. Maintaining efforts to minimise the impact of these risk factors, especially in low SDI locations, is necessary to sustain progress. Successes in moderating the smoking-related burden by reducing risk exposure highlight the need to advance policies that reduce exposure to other leading risk factors such as ambient particulate matter air pollution and high SBP. Troubling increases in high FPG, high BMI, and other risk factors related to obesity and metabolic syndrome indicate an urgent need to identify and implement interventions

Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

BACKGROUND Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mortality rates and life expectancy allow comparisons of the consequences of causes of death globally and over time, providing a nuanced understanding of the effect of these causes on global populations. METHODS The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 cause-of-death analysis estimated mortality and years of life lost (YLLs) from 288 causes of death by age-sex-location-year in 204 countries and territories and 811 subnational locations for each year from 1990 until 2021. The analysis used 56 604 data sources, including data from vital registration and verbal autopsy as well as surveys, censuses, surveillance systems, and cancer registries, among others. As with previous GBD rounds, cause-specific death rates for most causes were estimated using the Cause of Death Ensemble model-a modelling tool developed for GBD to assess the out-of-sample predictive validity of different statistical models and covariate permutations and combine those results to produce cause-specific mortality estimates-with alternative strategies adapted to model causes with insufficient data, substantial changes in reporting over the study period, or unusual epidemiology. YLLs were computed as the product of the number of deaths for each cause-age-sex-location-year and the standard life expectancy at each age. As part of the modelling process, uncertainty intervals (UIs) were generated using the 2·5th and 97·5th percentiles from a 1000-draw distribution for each metric. We decomposed life expectancy by cause of death, location, and year to show cause-specific effects on life expectancy from 1990 to 2021. We also used the coefficient of variation and the fraction of population affected by 90% of deaths to highlight concentrations of mortality. Findings are reported in counts and age-standardised rates. Methodological improvements for cause-of-death estimates in GBD 2021 include the expansion of under-5-years age group to include four new age groups, enhanced methods to account for stochastic variation of sparse data, and the inclusion of COVID-19 and other pandemic-related mortality-which includes excess mortality associated with the pandemic, excluding COVID-19, lower respiratory infections, measles, malaria, and pertussis. For this analysis, 199 new country-years of vital registration cause-of-death data, 5 country-years of surveillance data, 21 country-years of verbal autopsy data, and 94 country-years of other data types were added to those used in previous GBD rounds. FINDINGS The leading causes of age-standardised deaths globally were the same in 2019 as they were in 1990; in descending order, these were, ischaemic heart disease, stroke, chronic obstructive pulmonary disease, and lower respiratory infections. In 2021, however, COVID-19 replaced stroke as the second-leading age-standardised cause of death, with 94·0 deaths (95% UI 89·2-100·0) per 100 000 population. The COVID-19 pandemic shifted the rankings of the leading five causes, lowering stroke to the third-leading and chronic obstructive pulmonary disease to the fourth-leading position. In 2021, the highest age-standardised death rates from COVID-19 occurred in sub-Saharan Africa (271·0 deaths [250·1-290·7] per 100 000 population) and Latin America and the Caribbean (195·4 deaths [182·1-211·4] per 100 000 population). The lowest age-standardised death rates from COVID-19 were in the high-income super-region (48·1 deaths [47·4-48·8] per 100 000 population) and southeast Asia, east Asia, and Oceania (23·2 deaths [16·3-37·2] per 100 000 population). Globally, life expectancy steadily improved between 1990 and 2019 for 18 of the 22 investigated causes. Decomposition of global and regional life expectancy showed the positive effect that reductions in deaths from enteric infections, lower respiratory infections, stroke, and neonatal deaths, among others have contributed to improved survival over the study period. However, a net reduction of 1·6 years occurred in global life expectancy between 2019 and 2021, primarily due to increased death rates from COVID-19 and other pandemic-related mortality. Life expectancy was highly variable between super-regions over the study period, with southeast Asia, east Asia, and Oceania gaining 8·3 years (6·7-9·9) overall, while having the smallest reduction in life expectancy due to COVID-19 (0·4 years). The largest reduction in life expectancy due to COVID-19 occurred in Latin America and the Caribbean (3·6 years). Additionally, 53 of the 288 causes of death were highly concentrated in locations with less than 50% of the global population as of 2021, and these causes of death became progressively more concentrated since 1990, when only 44 causes showed this pattern. The concentration phenomenon is discussed heuristically with respect to enteric and lower respiratory infections, malaria, HIV/AIDS, neonatal disorders, tuberculosis, and measles. INTERPRETATION Long-standing gains in life expectancy and reductions in many of the leading causes of death have been disrupted by the COVID-19 pandemic, the adverse effects of which were spread unevenly among populations. Despite the pandemic, there has been continued progress in combatting several notable causes of death, leading to improved global life expectancy over the study period. Each of the seven GBD super-regions showed an overall improvement from 1990 and 2021, obscuring the negative effect in the years of the pandemic. Additionally, our findings regarding regional variation in causes of death driving increases in life expectancy hold clear policy utility. Analyses of shifting mortality trends reveal that several causes, once widespread globally, are now increasingly concentrated geographically. These changes in mortality concentration, alongside further investigation of changing risks, interventions, and relevant policy, present an important opportunity to deepen our understanding of mortality-reduction strategies. Examining patterns in mortality concentration might reveal areas where successful public health interventions have been implemented. Translating these successes to locations where certain causes of death remain entrenched can inform policies that work to improve life expectancy for people everywhere. FUNDING Bill & Melinda Gates Foundation

Functional MRI in the effect of transcranial magnetic stimulation therapy for patients with schizophrenia: a meta-analysis protocol

Introduction Schizophrenia is a psychiatric illness associated with brain function alterations and varying degree of treatment resistance, often leading to severe social malfunctioning. In recent decades, numerous studies have been investigating the therapeutic potential of transcranial magnetic stimulation (TMS) as a non-invasive therapy for schizophrenia. However, its clinical efficacy remains controversial, as a number of clinical trials indicated moderate therapeutic effect while others failed to reproduce the positive result. Moreover, the neurobiological mechanism of action remains unclear, possibly constricting the application of TMS in clinical practice. The present protocol of meta-analysis aims to investigate the TMS-related functional neuroimaging (ie, functional MRI) features and alterations in subjects with schizophrenia, and to discuss the potential of functional MRI in TMS researches.Methods and analysis The study selection process will follow the Preferred Reporting Items for Meta-Analyses guideline and quality assessment will be conducted with a customised checklist. We plan to search in the following databases: PubMed, Embase, OVID, China National Knowledge Infrastructure and Wanfang Data, from their respective dates of inception to 1 May 2020, with language restricted to English and Chinese. Studies focusing on the brain functional alterations in patients with schizophrenia treated by TMS will be retrieved.Ethics and dissemination This work does not require ethics approval as it will be based on published studies. This systematic review will be publicly disseminated in peer-reviewed journals.PROSPERO registration number CRD42020166288

Dynamic Strength Characteristics of Cement-Improved Silty Clay under the Effect of Freeze-Thaw Cycles

In the seasonally frozen soil regions of northern China, silty clay is widely used as a subgrade bed filler in heavy-haul railway construction. In this paper, the influence of freeze-thaw cycles on the dynamic strength properties (strength parameters and dynamic critical stress) of silty clay fillers before and after cement improvement was investigated by a series of dynamic triaxial tests under different confining pressure conditions, and the test results were quantified to analyze the improvement effects of cement improvement. The results show that cement modification can significantly improve the dynamic strength parameters (dynamic strength, dynamic strength index, and critical dynamic stress) of silty clay before and after freezing and thawing. The dynamic strength of cement-improved silty clay (CSC) was improved by 2.8 to 5.2 times compared to silty clay, and a high level of dynamic strength can be maintained after multiple freeze-thaw cycles. The dynamic cohesion was increased by 1.5 to 3 times and the dynamic internal friction angle was increased by 1.5 to 4 times. The attenuation rate of the critical dynamic stress of CSC with the number of freeze-thaw cycles was greater than that of the plain filler, while the relative lifting effect of the critical dynamic stress of the cement improvement was significant after three freeze-thaw cycles, and the maximum value was reached at a cycle number of three, with a relative increase of 2.5 times. A new index of critical dynamic stress attenuation of CSC for freeze-thaw cycles was introduced, which provides a useful reference for subgrade improvement and reinforcement along the silty clay railway in northern China

Valuation of Water Resource Green Efficiency Based on SBM–TOBIT Panel Model: Case Study from Henan Province, China

With progress in China’s industrialization and urbanization, the contradiction of social and economic development with water resource supply–demand and water environmental pollution becomes increasingly prominent. To cope with the dual constraints of resource shortage and environmental regulations, the concept of water resource green efficiency that considers economic, environmental, and ecological factors is highly involved to promote sustainable economic development. The theoretical and practice circle devote to scientific green efficiency assessment of water resources and effective recognition of relevant influencing factors. However, to an extent they neglect social benefits brought by sustainable development and possible influences of industrial restructuring on green efficiency. They also lack concern on green efficiency of water resources in inland arid areas. To offset the disadvantages of existing studies, the philosophy of sustainable development was integrated into the input–output assessment system of green efficiency of water resources, and an assessment model was constructed using the SBM–Tobit (slack-based measure and Tobit) method. Moreover, a case study based on Henan Province, China was carried out. The green efficiencies of water resources in 18 cities of Henan Province during 2011–2018 were calculated. The operation mechanism of relevant influencing factors was discussed, and the methods to improve green efficiency of water resources were determined. Results reveal that the sustainable green efficiency of water resources in Henan Province increased in fluctuation during 2011–2018. The mean green efficiency increased from 0.425 in 2011 to 0.498 in 2018. At present, green efficiency of water resources in Henan Province remains at a low level, with a mean of 0.504. Reducing water consumption intensity and increasing investment to water environmental pollution technologies can promote green efficiency of water resources significantly. Conclusions provide a new method for scientific measurement and green efficiency assessment of water resources in inland arid areas

再生水无计划间接补充饮用水的雌激素健康风险 Health risk induced by estrogens during unplanned indirect potable reuse of reclaimed water from domestic wastewater

以城市污水为水源的再生水中含有一定量的雌激素类内分泌干扰物，其在无计划间接补充饮用水过程中存在潜在健康风险。针对再生水经河流补给湖库型水源地的典型场景，研究了再生水中雌酮、雌二醇、17α-乙炔基雌二醇、双酚A、壬基酚和辛基酚在水体中的变化规律，评价了雌激素的健康风险。结果表明，再生水(二级出水)中雌激素类物质的质量浓度多分布在0.1~100 ng·L-1水平；双酚A和壬基酚的浓度较高，可达到1~10μg·L-1水平。再生水间接补充饮用水过程中，雌激素的浓度受到上游来水稀释、河道湖库自然降解和饮用水处理工艺去除等作用的影响。雌酮、雌二醇、双酚A、壬基酚和辛基酚的非致癌风险较小，都低于规定值1。当湖库型水源地的水力停留时间大于30 d时，再生水中17α-乙炔基雌二醇对人体的非致癌风险值大多小于1；当停留时间小于10 d且再生水占饮用水比例达50%以上时，16%~47%样品的17α-乙炔基雌二醇的非致癌风险值大于1，其健康风险需优先关注。 The estrogenic endocrine disruptors in reclaimed water from domestic wastewater may induce health risks to human being, when reclaimed water is used for augmentation of drinking water unplannedly and indirectly. This study investigated changes in concentrations of estrone, estradiol, 17alpha-ethinyl estradiol, bisphenol A, nonylphenol and octylphenol in reclaimed water during the reuse of reclaimed water for augmentation to water source such as lakes and reservoir via river. Thereafter, health risk induced by estrogens during the resue of reclaimed water was evaluated. The concentration of estrogen in secondary effluent ranged 0.1-100 ng x L(-1). The highest concentrations of bisphenol A and nonylphenol reached up to 1-10 microg x L(-1). During the indirect reuse of reclaimed water as potable water, the dilution and degradation in river and lake, and the removal by drinking water treatment process could change the concentrations of estrogen. The non-carcinogenic risks of estrone, estradiol, bisphenol A, nonylphenol and octylphenol were lower than 1. When the hydraulic retention time of 17alpha-ethinyl estradiol (EE2) in lakes and reservoir was higher than 30 days, the non-carcinogenic risk of EE2 was lower than 1 in most cases. When the hydraulic retention time of EE2 in lakes and reservoir was less than 30 days and the percentages of reclaimed water in drinking water were higher than 50%, the non-carcinogenic risk induced by EE2 was higher than 1 in 20%-50% samples. This indicated that the risks of EE2 should be concerned